EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know

EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know
Co-Chairs, Jessica Donington, MD, and Catherine Shu, MD, discuss NSCLC in this CME activity titled “EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GQW865. CME credit will be available until February 21, 2024.